YOLFTbeta
ProMIS Neurosciences Inc.

ProMIS Neurosciences Inc.

PMN · NASDAQ · Healthcare / Biotechnology

3.29USD-0.19 (-5.46%)

Price History

Full chart

Market Stats

Previous Close3.48
Open3.79
Day Range2.98 – 3.79
52-Week Range6.27 – 27.40
Volume156.50K
Market Cap95.51M
P/E (TTM)0.00
Forward P/E0.00
EPS-12.62
Dividend Yield0.00%
Beta-0.22
50-Day Avg13.82
200-Day Avg12.78

About

ProMIS Neurosciences, Inc. discovers and develops antibody therapies and therapeutic vaccines for neurodegenerative diseases and other misfolded protein diseases in Canada. The company's proprietary discovery platform comprises ProMIS, which enables drug discovery through a combination of protein biology, physics, and supercomputing. Its lead product candidates include PMN310, a monoclonal antibody (mAb) for toxic oligomers for treating Alzheimer's disease; PMN267 for the treatment of amyotrophic lateral sclerosis; and PMN442, a mAb targeting toxic a-syn oligomers and seeding fibrils for treating multiple system atrophy. The company also develops PNM440, an alpha-synuclein vaccine for treating multiple synucleinopathies; and PMN311, an amyloid-beta vaccine for the treatment of Alzheimer's. In addition, it is developing therapies for frontotemporal lobar degeneration, Huntington's disease, progressive supranuclear palsy, corticobasal degeneration, and schizophrenia. The company was formerly known as Amorfix Life Sciences Ltd. and changed its name to ProMIS Neurosciences, Inc. in July 2015. ProMIS Neurosciences, Inc. is headquartered in Toronto, Canada.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Neil K. Warma M.B.A.
  • Employees10
  • Headquarters1920 Yonge Street, Toronto, ON, Canada, M4S 3E2, USA
  • Websitehttps://www.promisneurosciences.com

Leadership

  • Mr. Eugene W. WilliamsCo-Founder & Chairman · b. 1959
  • Mr. Neil K. Warma M.B.A.CEO, President, Compliance Officer & Director · b. 1963
  • Dr. Neil R. Cashman M.D.Co-Founder, Co-Chairman of Scientific Advisory Board, Chief Scientific Officer & Director · b. 1952
  • Dr. Johanne Kaplan Ph.D.Chief Development Officer · b. 1960
  • Dr. Larry Douglas Altstiel M.D., Ph.D.Chief Medical Officer · b. 1950
  • Mr. Daniel E. Geffken M.B.A.Chief Financial Officer · b. 1957
  • Dr. David Wishart Ph.D.Chief Physics Officer
  • Mr. Dennis Chen Ph.D.Head of Manufacturing & Senior Consultant

Financials

Income Statement

Currency: USD2004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue-31.31K464.02K464.02K176.16K1.18M91.09K49.52K48.67K344.54K19.93K2.00K9.89K348.741.20K1.56K16.68K8.14K000
Growth (%)--+1381.83%0.00%-62.04%+571.97%-92.30%-45.64%-1.72%+607.97%-94.21%-89.96%+394.26%-96.48%+244.67%+30.20%+965.81%-51.21%-100.00%--
Cost of Revenue-------1.60M-1.10M1.06M1.87M3.70M-4.74M3.18M5.85M15.07K10.44M-33.36M
Gross Profit-31.31K219.92K193.63K176.16K1.18M91.09K-1.55M48.67K-759.86K-1.04M2.00K7.87K348.74-4.73M-3.18M-5.84M-15.07K-10.44M--33.36M
Gross Margin-100.00%47.39%41.73%100.00%100.00%100.00%-3133.02%100.00%-220.54%-5217.99%100.00%79.51%100.00%-393853.16%-203296.10%-35031.95%-185.17%---
Operating Expense-1.31M7.80M6.15M4.80M4.51M93.64K681.88K2.09M1.38M1.06M2.56M6.02M7.46M7.40M2.48M4.72M23.38B8.45M-6.80M
Operating Income-155.51K-1.27M-7.58M-5.95M-4.63M-3.33M-2.55K-2.23M-2.04M-2.14M-2.10M-2.56M-6.01M-7.46M-12.13M-5.66M-10.57M-23.38B-18.90M-16.83M-40.17M
Operating Margin--4069.85%-1633.06%-1283.06%-2625.85%-281.17%-2.80%-4510.11%-4188.80%-621.53%-10519.05%-127804.90%-60766.72%-2140457.07%-1009282.53%-361814.19%-63350.51%-287268384.39%---
EBITDA-155.51K-1.26M-7.41M-3.90M-4.48M-3.13M-2.49M-2.30M-2.02M-2.88M-1.51M-2.55M-4.78M-7.46M-7.39M-5.65M-9.33M-17.78B-17.81M2.86M-39.72M
EBITDA Margin--4038.13%-1597.21%-840.21%-2543.03%-264.19%-2730.51%-4650.20%-4158.44%-835.82%-7552.65%-127556.94%-48269.81%-2139052.30%-614617.22%-360823.39%-55923.23%-218464853.11%---
Net Income-156.72K-1.65M-7.11M-5.68M-4.50M-3.05M-2.55M-2.26M-2.04M-2.04M-1.53M-2.57M-4.79M-7.46M-7.40M-5.66M-11.98M-18.06B-17.51M2.78M-39.72M
Net Income Margin--5260.15%-1531.33%-1224.88%-2555.32%-257.78%-2799.05%-4573.24%-4188.80%-591.66%-7666.95%-128395.30%-48380.52%-2140457.07%-615329.37%-361814.19%-71819.34%-221930566.31%---
R&D63.66K944.20K2.95M6.06M3.27M3.62M3.25M2.04M1.77M1.27M763.96K1.39M3.15M5.44M4.74M3.18M4.95M16.09B7.88M10.64M33.38M
R&D as % of Total Revenue-3015.26%636.49%1306.51%1855.32%305.51%3565.78%4124.12%3631.81%369.95%3832.26%69326.77%31836.26%1559922.87%393953.16%203396.10%29671.32%197662624.25%---
Interest Expense1.21K1.61K3.67M6.99M193.63K131.51K46.98K13.53K2.29K-23.98K15.89K5.65K000416.29K282.06M201.39K76.78K0
Interest Expense % of Total Revenue-5.14%790.92%1505.39%109.92%11.11%51.58%27.32%4.70%-120.30%793.61%57.08%0.00%0.00%0.00%2495.72%3465713.20%---

Balance Sheet

Currency: USD2004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets594.68K4.76M11.34M5.41M4.37M3.23M1.29M321.81K316.29K294.54K1.15M967.82K2.17M2.97M2.07M1.38M22.44M12.60M13.62M18.91M9.18M
Total Liabilities99.77K212.62K575.14K596.12K472.01K634.39K400.08538.06K528.83K492.77K550.76K898.39K637.45K1.81M1.68M2.40M15.28M15.05M9.87M2.42M10.44M
Total Equity494.92K4.55M8.64M8.45M5.45M2.39M809.08-216.25K-212.54K-198.23K599.98K69.43K1.53M1.16M398.12K-1.02M7.16M-2.45M3.75M16.49M-1.26M
Cash-97.61K1.44M2.15M447.11K2.14M815.5636.26K47.07K25.01K903.21K712.04K1.69M2.39M1.66M1.03M21.43M10.69M12.60M13.29M6.12M
Total Debt25.85K---------118.28K120.86K----4.94M----
Net Debt25.85K-97.61K-1.44M-2.15M-447.11K-234.41K-815-36.26K-35.63K-25.01K-784.93K-591.18K-1.69M-2.39M-1.66M-1.03M-16.49M-10.69M-12.60M-13.29M-6.12M

Cash Flow

Currency: USD2005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-1.32M-5.40M-3.27M-3.96M-2.31M-2.31M-1.97M-1.63M-1.37M-1.13M-1.89M-4.53M-6.35M-6.09M-4.35M-9.44M-22.89M-10.84M-27.18M-28.12M
Investing Cash Flow-4.59M5.12M5.12M-11.65K3.62M510.31K89.87K89.87K-2.00K-29.55K-152-163-151-208-111.88K95.93K-2.66K-1.35K-693-702
Financing Cash Flow5.54M820.80K215.90K3.65M485.88K658.63K1.12M1.72M1.26M1.80M1.75M5.31M6.86M5.36M3.83M25.63M8.73M17.75M27.88M20.94M
Capital Expenditure80.66K181.51K493.29K89.71K11.37K21.73K4.64K1.25K1.99K02.59M05.45108.67K108.67K6.12K2.66K000
Free Cash Flow-1.37M-3.13M-5.90M-3.36M-3.97M-2.33M-2.34M-1.97M-1.63M-1.13M-1.89M-4.53M-6.35M-6.09M-4.46M-9.45M-22.89M-10.84M-27.18M-28.12M
FCF to OCF103.72%57.83%180.28%84.94%171.69%100.94%118.75%121.19%118.60%100.00%100.00%100.00%100.00%100.00%102.50%100.06%100.01%100.00%100.00%100.00%

Earnings

Report DateJun 8, 2012Aug 14, 2012Nov 28, 2012Feb 14, 2013Mar 31, 2013Jul 1, 2013Jun 13, 2014Aug 7, 2014Nov 12, 2014Jan 1, 2015May 22, 2015Aug 13, 2015Nov 10, 2015Mar 23, 2016May 11, 2016Aug 12, 2016Nov 2, 2016Mar 15, 2017May 9, 2017Aug 11, 2017Nov 13, 2017Mar 14, 2018May 11, 2018Aug 14, 2018Nov 13, 2018Mar 15, 2019May 14, 2019Aug 13, 2019Nov 14, 2019Mar 18, 2020May 13, 2020Aug 13, 2020Nov 11, 2020Mar 31, 2021May 14, 2021Aug 12, 2021Nov 12, 2021Mar 17, 2022May 13, 2022Aug 15, 2022Nov 14, 2022Mar 8, 2023May 15, 2023Aug 14, 2023Nov 14, 2023Mar 6, 2024May 14, 2024Aug 8, 2024Nov 14, 2024Mar 31, 2025May 12, 2025Aug 13, 2025Nov 12, 2025Mar 25, 2026Apr 6, 2026Aug 13, 2026Nov 11, 2026
EPS Estimate---------------------0.01-0.01-0.01-0.01-0.01-0.01-0.01-0.01-0.01-0.01-0.43-0.60-0.60-0.45-1.49------0.85--0.58-0.27-11.42-0.27-6.87-4.85-2.42-0.16-4.30-6.04-9.99-6.71-0.20-1.45-1.40
EPS Actual-20.53-15.98-15.13-13.31-0.58-14.59-0.60-0.75-0.57-0.40-0.30-0.20-0.24-0.29-0.19-0.20-0.23-0.30-0.32-0.42-0.01-0.01-0.01-0.01-0.01-0.01-0.01-0.01-0.01-0.01-0.01-0.60-0.60-0.11-1.22-0.05-0.13-0.32-0.60-0.48-1.11-1.17-0.58-0.27-6.52-0.29-6.48-4.4710.860.12-7.35-9.98-8.40-30.05-1.26-1.28-
Surprise--------------------0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%97.67%0.00%0.00%75.76%17.83%------30.59%-0.33%0.00%42.91%-7.41%5.68%7.84%548.76%175.00%-70.93%-65.23%15.92%-347.84%-516.10%11.72%-
Timing------After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursPre-marketPre-market-Pre-marketPre-marketPre-marketPre-market-After-hours-

Key Statistics & Ratios

Market Cap95.51M
Enterprise Value65.54M
Trailing P/E0.00
Forward P/E0.00
Price / Sales4016.22
Price / Book2.41
EPS-12.62
Book Value5.51
Revenue (TTM)7.56K
Gross Profit (TTM)-35.66M
EBITDA-13.31M
Profit Margin0.00%
Operating Margin0.00%
Return on Equity-172.30%
Return on Assets-81.06%
Shares Outstanding8.97M
Shares Float4.38M
Beta-0.22
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Strong Buy
Based on 3 analystsTarget 42.74
  • Strong Buy
    2
  • Buy
    1

Ownership Breakdown

Institutions
77.26%
Insiders
11.87%
Retail / Other
10.87%

Top Institutional Holders

  • HHG PLC
    1.29M14.42%
  • Deep Track Capital, LP
    835.65K9.32%
  • Wellington Management Company LLP
    696.38K7.77%
  • Ally Bridge Group (NY) LLC
    620.32K6.92%
  • Trails Edge Capital Partners, LP
    557.10K6.21%
  • Woodline Partners LP
    395.30K4.41%
  • Yu Fan
    329.76K3.68%
  • Sphera Funds Management Ltd.
    325.59K3.63%
  • Squadron Capital Management LLC
    324.98K3.62%
  • Adage Capital Partners Gp LLC
    164.28K1.83%
  • ADAR1 Capital Management LLC
    95.35K1.06%
  • 683 Capital Management LLC
    92.85K1.04%
  • Great Point Partners LLC
    86.15K0.96%
  • Millennium Management LLC
    56.05K0.63%
  • Ikarian Capital, LLC
    55.00K0.61%
  • Heights Capital Management Inc
    50.66K0.56%
  • BOOTHBAY FUND MANAGEMENT, LLC
    16.04K0.18%
  • Bank of Montreal
    11.37K0.13%
  • Seven Fleet Capital Management LP
    10.60K0.12%

Top Fund Holders

  • Fidelity Nasdaq Composite Index
    5.82K0.06%

Stock Splits

  • Nov 28, 20251:25
  • Jun 28, 20221:60